Arsenal Biosciences, Inc. — Form D
Arsenal Biosciences, Inc. of South San Francisco, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-09-09. The offering totals $230.8M, of which $220.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-09-09
- Form: D
- Accession: 0001945638-22-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $230.8M
- Amount sold: $220.8M
- Remaining: $10.0M
- Investors: 17
- Date of first sale: 2022-02-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-458499
Issuer
- Name: Arsenal Biosciences, Inc.
- CIK: 0001945638
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 329 Oyster Point Blvd, South San Francisco, CA, 94080
- Phone: (650) 240-8844
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Margaret Nibbi | Executive Officer | South San Francisco, CA |
| Matthew Fust | Director | SOUTH SAN FRANCISCO, CA |
| Beth Seidenberg | Director | South San Francisco, CA |
| Valentin Barsan | Director | South San Francisco, CA |
| Brook Byers | Director | San Francisco, CA |
| Sean Parker | Director | South San Francisco, CA |
| James Ahlers | Executive Officer | Hayward, CA |
| Kenneth Drazan | Director | South San Francisco, CA |
| Kenneth Drazan | Executive Officer | South San Francisco, CA |
| Irene Pleasure | Executive Officer | South San Francisco, CA |
Other filings by this issuer (2)
More